Skip to content

Solesta Injectable Gel

by Palette Life Sciences Inc.

PMA P100014

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

PMA P100014↗

FDA record

Trust

Unverified

Source FDA PMA, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP100014 Date27 May 2011ApprovedStatusActive

Official records

From the FDA record

FDA PMA P100014

Received by the FDA
9 Apr 2010
FDA decision
27 May 2011
FDA review time
413 days from receipt to decision
Docket number
11M-0445
Approval order statement, verbatim
APPROVAL FOR THE SOLESTA. THIS DEVICE IS INDICATED FOR THE TREATMENT OF FECAL INCONTINENCE IN PATIENTS 18 YEARS AND OLDER WHO HAVE FAILED CONSERVATIVE THERAPY (E.G., DIET, FIBER THERAPY, ANTI-MOTILITY MEDICATIONS).

From the FDA PMA record P100014 (openFDA), as read on 8 Nov 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
FDA applicant
Palette Life Sciences
PMA number
FDA product code
LNM
Device class
Class III
Advisory committee
Gastroenterology, Urology
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Solesta Injectable Gel is an agent, bulking, injectable for gastro-urology use. It is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy such as diet, fiber therapy, or anti-motility medications.

The device is supplied as an injectable gel and is intended for use under medical supervision. It is a single-use product, and its authorization is based on FDA PMA approval (P100014). No information on sterility, MRI safety, sizes, or storage is provided in the data.

Devices cleared under P100014

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under P100014
UDI-DISize and differences
Solesta Gel 1.0 mL Syringe
Palette Life Sciences Inc.
011506 / Gel 1.0 mL Syringe00850004725016
Total Volume 1 mL
On the market

Similar devices

Other devices filed under FDA product code LNM (Agent, Bulking, Injectable For Gastro-Urology Use).

Other devices from Palette Life Sciences Inc.

See all devices from Palette Life Sciences Inc. →